The invention relates to the use of a compound selected from: [.alpha.-(tert-butylaminomethyl)-3,4-dichlorobenzyl]thioacetamide and its laevorotatory isomer, [.alpha.-(tert-amylaminomethyl)-3,4-dichlorobenzyl]thioacetamide and its isomers, [.alpha.-(1-adamantylaminomethyl)3,4-dichlorobenzyl]thioacetamide and its isomers, as well as the addition salts of these compounds with pharmaceutically acceptable acids, for inhibiting dopamine reuptake.

Вымысел относит к пользе смеси выбранной от: [ alpha.-(tert-butylaminomethyl)-3,4-dichlorobenzyl]thioacetamide и свой laevorotatory изомер, [ alpha.-(tert-amylaminomethyl)-3,4-dichlorobenzyl]thioacetamide и свои изомеры, [ alpha.-(1-adamantylaminomethyl)3,4-dichlorobenzyl]thioacetamide и свои изомеры, также,как соли добавлению этих смесей с фармацевтически приемлемо кислотами, для блокируя reuptake допамина.

 
Web www.patentalert.com

< (none)

< Compounds and methods for treating mitochondria-associated diseases

> Use of valproic acid analog for the treatment and prevention of migraine and affective illness

> (none)

~ 00009